Your browser doesn't support javascript.
loading
The Acute Kidney Intervention and Pharmacotherapy (AKIP) List: Standardized List of Medications That Are Renally Eliminated and Nephrotoxic in the Acutely Ill.
Barreto, Erin F; Gaggani, Alexis M; Hernandez, Brandy N; Amatullah, Nabihah; Culley, Colleen M; Stottlemyer, Britney; Murugan, Raghavan; Ozrazgat-Baslanti, Tezcan; Bihorac, Azra; Kellum, John A; Kashani, Kianoush B; Rule, Andrew D; Kane-Gill, Sandra L.
Afiliación
  • Barreto EF; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Gaggani AM; Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
  • Hernandez BN; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Amatullah N; Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
  • Culley CM; Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
  • Stottlemyer B; Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
  • Murugan R; Program for Critical Care Nephrology, Department of Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Ozrazgat-Baslanti T; Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.
  • Bihorac A; Division of Nephrology, Hypertension, and Renal Transplantation, Department of Medicine, University of Florida, Gainesville, FL,USA.
  • Kellum JA; Intelligent Clinical Care Center, University of Florida, Gainesville, FL, USA.
  • Kashani KB; Department of Surgery and Anesthesiology, University of Florida, Gainesville, FL, USA.
  • Rule AD; Program for Critical Care Nephrology, Department of Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Kane-Gill SL; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Ann Pharmacother ; : 10600280241273191, 2024 Sep 04.
Article en En | MEDLINE | ID: mdl-39230007
ABSTRACT
The objective of this project was to develop a standardized list of renally eliminated and potentially nephrotoxic drugs that will help inform initiatives to improve medication safety. Several available lists of medications from the published literature including original research articles and reviews, and from regulatory agencies, tertiary references, and clinical decision support systems were compiled, consolidated, and compared. Only systemically administered medications were included. Medication combinations were included if at least 1 active ingredient was considered renally dosed or potentially nephrotoxic. The medication list was reviewed for completeness and clinical appropriateness by a multidisciplinary team of individuals with expertise in critical care, nephrology, and pharmacy. An initial list of renally dosed and nephrotoxic drugs was created. After reconciliation and consensus from clinical experts, a standardized list of 681 drugs is proposed. The proposed evidence-based standardized list of renally dosed and potentially nephrotoxic drugs will be useful to harmonize epidemiologic and medication quality improvement studies. In addition, the list can be used for clinical purposes with surveillance in nephrotoxin stewardship programs. We suggest an iterative re-evaluation of the list with emerging literature and new medications on an approximately annual basis.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Ann Pharmacother Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Ann Pharmacother Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos